Profile
| Role | Director, 10% Owner |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Schwab Andrew J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $10.00M. Lifetime open-market sales: $801K.
| Role | Director, 10% Owner |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-11 | CAMP | Camp4 Therapeutics Corp | A — Grant or award | 2.94M | $1.53 | $4.50M |
| 2025-08-21 | SKYE | Skye Bioscience, Inc. | S — Open-market sale | 6.5K | $3.42 | $22K |
| 2025-08-21 | SKYE | Skye Bioscience, Inc. | S — Open-market sale | 164.0K | $3.42 | $561K |
| 2025-08-21 | SKYE | Skye Bioscience, Inc. | S — Open-market sale | 2.3K | $3.57 | $8K |
| 2025-08-21 | SKYE | Skye Bioscience, Inc. | S — Open-market sale | 58.6K | $3.57 | $209K |
| 2024-10-15 | CAMP | Camp4 Therapeutics Corp | P — Open-market purchase | 909.1K | $11.00 | $10.00M |
| 2024-10-15 | CAMP | Camp4 Therapeutics Corp | J — Other acquisition / disposition | 302.8K | — | |
| 2024-10-15 | CAMP | Camp4 Therapeutics Corp | J — Other acquisition / disposition | 378.5K | — | |
| 2024-10-15 | CAMP | Camp4 Therapeutics Corp | J — Other acquisition / disposition | 1.34M | — |
Schwab Andrew J. is a corporate insider — currently tracked as Director, 10% Owner of Camp4 Therapeutics Corp (CAMP). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($10.00M) and 4 open-market sales ($801K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Schwab Andrew J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.